Companies: 10,795·Total market cap: $144.5T
Gerresheimer AG

Gerresheimer AG

GRRMFOTCHealthcare● Active
$32.20
+$0.10(+0.31%)
Market Cap$1.1B
P/E Ratio
52W High$73.8
52W Low$19.165
Overview

Gerresheimer AG (GRRMF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

GRRMF · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
34.5M +3.61% YoY Change
FY · as of Nov 30, 2024 · Reported in EUR
vs 33.3M in FY 2023
Diluted Shares Outstanding
34.5M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+3.61%
year-over-year
Float (Free Float)
32.0M
publicly tradable shares
92.8% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+3.2%
2021 → 2024
5-Year CAGRincreasing
+1.9%
2019 → 2024
10-Year CAGRincreasing
+1.0%
2014 → 2024

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2024Latest
Diluted Shares: 34.5M
34.5M
+3.61%
FY 2023
Diluted Shares: 33.3M
33.3M
+6.17%
FY 2022
Diluted Shares: 31.4M
31.4M
+0.00%
FY 2021
Diluted Shares: 31.4M
31.4M
+0.00%
FY 2020
Diluted Shares: 31.4M
31.4M
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs GRRMF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
Gerresheimer AGGRRMF
Gerresheimer AGYOU
34.5M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Gerresheimer AG (GRRMF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of November 30, 2024, Gerresheimer AG reports 34.5M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Gerresheimer AG's basic shares outstanding (34.5M) represents currently issued shares. Diluted shares outstanding (34.5M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Gerresheimer AG's float is 32.0M (92.8% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float32.0M(92.8%)
Outstanding34.5M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · EUR

About shares outstanding & methodology

Gerresheimer AG (GRRMF) shares outstanding history from 2005 to 2024. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Gerresheimer AG shares outstanding for the fiscal year ending November 30, 2024 were 34.5M, a 3.61% increase year-over-year. Gerresheimer AG FY 2024 shares outstanding were 34.5M, a +3.61% increase from FY 2023.

Gerresheimer AG is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +1.0% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

GRRMF shares outstanding · 4 questions

As of November 30, 2024, Gerresheimer AG (GRRMF) has approximately 34.5M basic shares outstanding and 34.5M diluted shares outstanding. This represents a +3.61% year-over-year increase from FY 2023 (33.3M). The increase may reflect equity compensation issuances or secondary offerings.

GRRMF shares outstandinghow many shares does GRRMF haveGRRMF basic shares 2024GRRMF diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Gerresheimer AG SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08